... genes and initiate epithelial- mesenchymaltransition Complexes of Smad7 and Smurf1 or Smurf2 promote ubiquination and degradation of activated receptors limiting the intensity and duration of signaling ... environment on neoplasia The role of the ECM and stroma in cancer Drivers and mediators of epithelial- mesenchymaltransition (EMT) Early stage tumor cells maintain epithelial properties similar to the ... receptors of tumor cells A comprehensive gene expression profile ofbreast carcinomas noted significant overexpression of the chemokines CXCL14 and CXCL12 in tumor myoepithelial cells and myofibroblasts...
... guideline (‘Familial breast cancer: the classification and care of women at risk of familial breastcancer in primary, secondary and tertiary care’) gives details of the methods and the evidence ... dominant inheritance of early onset breastcancerCancer 73: 643–51 Collaborative Group of Hormonal Factors in BreastCancer (2001) Familial breast cancer: collaborative reanalysis of individual data ... context of this guideline: All affected relatives must be on the same side of the family and be blood relatives of the woman and each other In cases of bilateral breast cancer, each breast cancer...
... of 10 rats MRI and BLI Euthanized of rats MRI and BLI Euthanized all rats MRI Baseline 106 FEPro labeled 231BRL MRI and BLI MRI and BLI MRI and BLI MRI and BLI MRI and BLI MRI and BLI - Euthanize ... MRI and BLI MRI and BLI MRI and BLI MRI and BLI MRI and BLI MRI and BLI - Euthanize rats - Page of 10 (page number not for citation purposes) Journal of Translational Medicine 2009, 7:88 tion and ... development of metastatic breastcancer was organ dependant Figure contains representative BLI and MRI of the distribution of metastases in the spinal cord and bones Prussian blue Page of 10 (page...
... Frequencies and percentages of women who received standard of care and addition to standard of care are presented in Table Only two-thirds of all breastcancer cases received standard of care No ... Americans and Whites in receipt of standard of care or addition to standard of care (Table 3) Stage at diagnosis and area of residence were statistically significant in both the standard of care and ... were more likely to have received standard of care and addition to standard of care compared to Whites Therefore, meeting or exceeding standard of care ofbreastcancer treatment does not explain...
... Reirradiation of recurrent breast carcinoma of the recurrence and a subgroup of patients (n = 13) are shown Figure Reirradiation of recurrent breast carcinoma Survival proportions of a subgroup of patients ... treatment of patients, and helped to draft the manuscript CP participated in the design of the study and treatment of patients, and helped to draft the manuscript CW participated in the design of the ... results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment ofbreastcancer N Engl J Med 1989, 320:822-828 Kurtz JM, Amalric R, Brandone...
... accurately and inexpensively help define the therapeutic potential of candidate biomarkers, such as IGF-1 for the early detection ofbreastcancer These studies are important since the breast cancers ... IGFBP-3 andbreastcancer in young women: a pooled re-analysis of three prospective studies Eur J Cancer Prev 2005, 14:493-6 Renehan AG, Frystyk J, Flyvbjerg A: Obesity andcancer risk: the role of ... protein can be associated with the progression ofbreast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women Oncology 1999, 57:330-40...
... Early BreastCancer Trialists' Collaborative Group (EBCTCG) Effects of chemotherapy and hormonal therapy for early breastcancer on recurrence and 15-year survival: an overview of the randomised ... classification ofbreastcancer by the WHO (1968) and its prognostic value] Arkh Patol 1980;42(4): 13–19 Singletary SE, Greene FL: Revision ofbreastcancer staging: the 6th edition of the TNM Classification ... rate and MIB–1 index in patients with pT1–2 breastcancer Anticancer Res 2004; 24(5): 3221–3224 Stein RC, Zvelebil MJ: The application of 2D gel-based proteomics methods to the study ofbreast cancer...
... with breastcancer [22,23] Estrogen receptors and progesterone receptors have been suggested to play a role in breast cancers in men, and they are present in about 90% and 81% ofbreast cancers ... Because of weakness and quick deterioration of health state of the patient, it was not possible to perform a biopsy documentation of recurrence and determination of hormone receptor status and HER-2 ... breastcancer [21] The risk of subsequent contralateral breastcancer was highest for men aged less than 50 years at the time of the first cancer diagnosis, which is consistent with studies of...
... with both the nervous system and the underlying cancer Each of these antibodies is associated with a narrow spectrum of clinical syndromes and a restricted subgroup of cancers [2] Paraneoplastic ... Pattern of serum IgG and CK levels with time from treatment Pattern of serum IgG and CK levels with time from treatment Page of (page number not for citation purposes) World Journal of Surgical ... review of 31 reported cases of paraneoplastic neurological syndromes due to breastcancer reported only 29% of patients responded to chemotherapy with an improvement in neurological deficits [3] Often...
... diagnosis of ACR grade and lesions and for assessment of tissue andmolecular signature First, FNA is a rapid and cost-effective tool for breastcancer diagnosis in a one-stop multidisciplinary breast ... of late radiation-induced toxicity Biological tools: To determine breastcancer patients at high risk of local relapse The current locoregional management of early breastcancer consists ofbreast ... prognostic role of a gene signature from tumorigenic breast- cancer cells N Engl J Med 2007, 356:217-26 van Beers EH, Nederlof PM: Array-CGH andbreastcancerBreastCancer Res 2006, 8:210 Andre F, Michiels...
... data analysis and drafting of the manuscript MF and BH performed data analysis and drafting the manuscript US carried out design, study and drafting of the manuscript All authors read and approved ... Journal of Nanobiotechnology 2010, 8:14 http://www.jnanobiotechnology.com/content/8/1/14 Page of Figure B-factors of the Lys chains averaged on 10 ns of MD simulation stand channel dynamics and to ... Detailed kinetic results of the TMB assay of FhuA Δ1-160 variants are available in Additional file 1: Figure S1 Additional material Additional file Molecularunderstandingof sterically controlled...
... as diagnostic tools for breastcancerand also furthers our understandingof the role of miRNAs in tumorigenesis Two previous studies of miRNA expression in human breastcancer have focused on ... comprehensive set of miRNA expression profiles for primary human breastcancer we selected 99 primary human tumors, normal breast samples and 33 breastcancer cell lines for miRNA expression profiling ... CB, CC and EAM conceived and designed the study ARG and IOE provided breastcancer samples and clinical information CB, IS and SC performed the experiments under the supervision of CC and EAM...
... treatment of disease states like breastcancer 1.4 Rationale and purpose of this study Breast carcinoma is a common cancer in women and is a leading cause of cancerrelated deaths in Singapore and worldwide ... the baseline scores ofbreastcancer patients in Singapore receiving herbal TCM therapy………… 63 Figure BR-23 scores ofbreastcancer patients at baseline and after 11-13 weeks of TCM treatment……………………………………………… ... Results of cytotoxicity assays of Solanum nigrum and Scutellaria barbata in MCF-7 human breastcancer cell lines … 82 3.5.2.2 Results of cytotoxicity assays of Solanum nigrum and in...
... treatment of ER positive breastcancerand in the reduction ofbreastcancer risk [42–44] Side effects of DCL included acute toxicities such as hypersensitivity, hypotension, nausea and pain; ... the fight against breast cancer, the totality of tumour treatment dictated therapy outcome and the probability ofcancer remission Differential metabolism of docetaxel (DCL) and tamoxifen (TAM), ... towards combination of DCL and TAM—as an in vitro model ofcancer to investigate the reduction of antagonistic effects of DCL and TAM, in DDNPs versus free drugs The viability of the MCF7 cell line,...
... treatment of ER positive breastcancerand in the reduction ofbreastcancer risk [42–44] Side effects of DCL included acute toxicities such as hypersensitivity, hypotension, nausea and pain; ... the fight against breast cancer, the totality of tumour treatment dictated therapy outcome and the probability ofcancer remission Differential metabolism of docetaxel (DCL) and tamoxifen (TAM), ... towards combination of DCL and TAM—as an in vitro model ofcancer to investigate the reduction of antagonistic effects of DCL and TAM, in DDNPs versus free drugs The viability of the MCF7 cell line,...
... Progression ofBreastCancer 1.2 Epithelial- MesenchymalTransition (EMT) 1.2.1 EMT in Normal Development 11 1.2.2 EMT in BreastCancer 12 1.2.3 Recent Findings Linking EMT with Basal- like Phenotype in Breast ... the role of genetics in the pathology ofbreastcancer About 20 to 30% of women diagnosed with breastcancer have a family history ofbreastcancer It is estimated that to 10% ofbreastcancer ... TABLE OF CONTENTS i Acknowledgements Summary vii List of Tables ix List of Figures x Abbreviations xii Introduction 1 1.1 BreastCancer 1.1.1 Incidence ofBreastCancer 1.1.2 Etiology ofBreast Cancer...
... effects of RGZ and CGZ were maintained in the presence of GW9662 (RGZ Figure 4B, CGZ data not shown) Figure Regulation ofbasal E-cadherin and N-cadherin expression by PPARg ligands (A) Effect of ... Page of 13 Figure Regulation of TGF-b1-induced E-cadherin expression by PPARg ligands (A) Effect of TGF-b1 on expression ofepithelial marker E-cad (n = 4) (B) Effect of RGZ on regulation of E-cad ... http://respiratory-research.com/content/11/1/21 Page of 13 Figure Regulation of TGF-b1-induced N-cadherin expression by PPARg ligands (A) Effect of TGF-b1 on expression ofmesenchymal marker N-cad (n = 4) (B) Effect of PPARg ligands on...
... morphology and migration 73 Figure 4.3 Expression levels of epithelial- , EMT- and mesenchymalrelated markers in P1 and P2 cells 75 x Figure 4.4 Changes in the expression of EMT- and mesenchymalrelated ... promotes cancer progression and metastasis via epithelial- mesenchymaltransition (EMT) , angiogenesis and immuno-suppression (Wakefield and Roberts, 2002) 11 Interestingly, some of the biological ... Introduction 63 4.1.1 Properties ofepithelial cells andmesenchymal cells 63 4.1.2 Epithelial- MesenchymalTransition 64 4.1.3 Regulatory factors controlling EMT 66 4.1.4 TGF-β and Wnt signaling pathways...
... levels of key epithelialandmesenchymal markers 20 There are several molecules that are important features ofEMTand cell adhesions Paxillin is part of a complex of cytoskeletal proteins and ... target for cancer therapy The broad ranging expression of PRL-3 in colorectal, breast, ovarian, gastric and liver cancer, and its emergence as a key player in transformation and metastasis ofcancer ... affects a number of important cell processes involved in progression ofcancer 14 Transformed cell morphology and altered cell adhesion are reminiscent ofEpithelialMesenchymal Transition, which...
... total cancer cases and 22 % of the cancer deaths The age-standardized incidence rate ofbreastcancer increased from 29/100 000 in 1996 to 50/100 000 in 2008 Breastcancer comprises 37 % of all ... better understandingof Jordanian women’s views ofbreastcancerand their breast health-seeking behaviour Breast health awareness interventions need to address women’s fears from breastcancer ... andbreastcancer does not mean the end of life” (2, 2) Comfort in acquiring breast health knowledge and skills In all the FGDs, women talked about seeing or hearing about breastcancerand breast...